All Posts

Stories

News Publications
Commercialization

In conversation with Praxis SCI Accelerate Cohort Member, munevo

January 6, 2023
munevo GmbH / munevo Inc. is an early stage medical device company that focuses on assistive technology based on smart glasses. Many people with…
Read More
Commercialization

In conversation with Praxis SCI Accelerate Cohort Member, Comphya

January 5, 2023
Comphya, a Swiss medical device company, is developing the first implantable neurostimulator to treat erectile dysfunction (ED). The device, CaverSTIM, aims to…
Read More
Man using a wheelchair descends a blue glass ramp alongside a walking woman
Stories

Praxis Year-end Review 2022

December 13, 2022
Throughout 2022, Praxis Spinal Cord Institute has continued its work to improve quality of life for people living with spinal cord injury.…
Read More
Stories

Praxis Staff Spotlight: Dr. Nader Fallah

December 8, 2022
Meet Dr. Nader Fallah, who is the Associate Director of Artificial Intelligence (AI) Research here at Praxis. Nader develops tools that help…
Read More
Stories

Praxis Staff Spotlight: Gwen Dziwenko

October 19, 2022
Meet Gwen Dziwenko! She’s the National Clinical Liaison on the Care Team at Praxis, based in the Interior Health Region in BC.
Read More
Praxis News

Praxis CEO, Bill Barrable talks to CEO of ABI Wellness, Mark Watson, and Host Brain Mastery Podcast 

October 6, 2022
Praxis CEO, Bill Barrable took part in the Brain Mastery podcast. Invited by host, Mark Watson CEO of ABI Wellness, Bill talks about…
Read More
Praxis Spinal Cord Injury Placeholder Icon
Commercialization

In conversation with Praxis SCI Incubate Cohort Member, NovaSense

September 20, 2022
NovaSense is a sensing technology that combats pressure injuries. Not only is the technology capable of continuous and accurate pressure monitoring over…
Read More
Stories

World SCI Day 2022

September 1, 2022
The International Spinal Cord Society (ISCoS) recognizes September 5th as Spinal Cord Injury Day. In honor of this day, Praxis CEO Bill…
Read More
Commercialization

In conversation with Praxis SCI Incubate Cohort Member, Neuro Vigor

August 29, 2022
Neuro Vigor is developing a new class of drugs that reduce reactive aldehydes to treat neuropathic pain in SCI, a largely unmet…
Read More
Commercialization

In conversation with Praxis SCI Incubate Cohort Member, NanoTess

August 23, 2022
NanoTess is a material science company whose first product, NanoSALV, is a nanotechnologyenabled medical device designed to treat chronic wounds. It was…
Read More
Commercialization

In conversation with Praxis SCI Incubate Cohort Member, NeuralDrive

August 17, 2022
NeuralDrive is a spin-out from research at Université de Montréal. The company is developing a neural interface to improve rehabilitation through neurostimulation…
Read More
Commercialization

In conversation with Praxis SCI Incubate cohort member, Kalogon

August 9, 2022
Kalogon is a company based out of Brevard County, Florida on a mission to alleviate pressure injuries and chronic pain in people…
Read More